Erschienen in:
01.04.2013 | Gastrointestinal Oncology
Novel Multimodality Treatment Sequencing for Extrahepatic (Mid and Distal) Cholangiocarcinoma
verfasst von:
Kiran K. Turaga, MD, MPH, Susan Tsai, MD, MHS, Lauren A. Wiebe, MD, Douglas B. Evans, MD, T. Clark Gamblin, MD, MS
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 4/2013
Einloggen, um Zugang zu erhalten
Abstract
Neoadjuvant chemoradiation has demonstrated significant advantages in the management of pancreatic adenocarcinoma. A similar tumor in a nearby anatomical location is extrahepatic cholangiocarcinoma, which has proven to be largely unresponsive to current forms of therapy. Neoadjuvant therapy for hilar cholangiocarcinoma has been combined with surgical resection and/or liver transplantation with a 25–33 % complete pathological response rate. We propose a wider application of neoadjuvant chemoradiation for patients with distal cholangiocarcinoma and present our rationale for this form of treatment sequencing.